381 related articles for article (PubMed ID: 22910528)
1. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial.
Mozaffari-Khosravi H; Yassini-Ardakani M; Karamati M; Shariati-Bafghi SE
Eur Neuropsychopharmacol; 2013 Jul; 23(7):636-44. PubMed ID: 22910528
[TBL] [Abstract][Full Text] [Related]
2. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.
Mischoulon D; Best-Popescu C; Laposata M; Merens W; Murakami JL; Wu SL; Papakostas GI; Dording CM; Sonawalla SB; Nierenberg AA; Alpert JE; Fava M
Eur Neuropsychopharmacol; 2008 Sep; 18(9):639-45. PubMed ID: 18539007
[TBL] [Abstract][Full Text] [Related]
3. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
5. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
[TBL] [Abstract][Full Text] [Related]
6. The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.
Peters BS; Wierzbicki AS; Moyle G; Nair D; Brockmeyer N
Clin Ther; 2012 Jan; 34(1):67-76. PubMed ID: 22212377
[TBL] [Abstract][Full Text] [Related]
7. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
8. Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.
van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Olderikkert MG; Beekman AT; de Groot LC
J Am Geriatr Soc; 2009 Aug; 57(8):1481-6. PubMed ID: 19549020
[TBL] [Abstract][Full Text] [Related]
9. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial.
Rogers PJ; Appleton KM; Kessler D; Peters TJ; Gunnell D; Hayward RC; Heatherley SV; Christian LM; McNaughton SA; Ness AR
Br J Nutr; 2008 Feb; 99(2):421-31. PubMed ID: 17956647
[TBL] [Abstract][Full Text] [Related]
10. Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.
Lucas M; Asselin G; Mérette C; Poulin MJ; Dodin S
Am J Clin Nutr; 2009 Feb; 89(2):641-51. PubMed ID: 19116322
[TBL] [Abstract][Full Text] [Related]
11. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.
Jazayeri S; Tehrani-Doost M; Keshavarz SA; Hosseini M; Djazayery A; Amini H; Jalali M; Peet M
Aust N Z J Psychiatry; 2008 Mar; 42(3):192-8. PubMed ID: 18247193
[TBL] [Abstract][Full Text] [Related]
12. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
[TBL] [Abstract][Full Text] [Related]
13. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study.
Souied EH; Delcourt C; Querques G; Bassols A; Merle B; Zourdani A; Smith T; Benlian P;
Ophthalmology; 2013 Aug; 120(8):1619-31. PubMed ID: 23395546
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression.
Marangell LB; Martinez JM; Zboyan HA; Kertz B; Kim HF; Puryear LJ
Am J Psychiatry; 2003 May; 160(5):996-8. PubMed ID: 12727707
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial.
Smith DJ; Sarris J; Dowling N; O'Connor M; Ng CH
Nutr Neurosci; 2018 Apr; 21(3):224-228. PubMed ID: 28224818
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo-controlled study.
Bot M; Pouwer F; Assies J; Jansen EH; Diamant M; Snoek FJ; Beekman AT; de Jonge P
J Affect Disord; 2010 Oct; 126(1-2):282-6. PubMed ID: 20466431
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
[TBL] [Abstract][Full Text] [Related]
18. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
19. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial.
van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Hoefnagels WH; Beekman AT; de Groot LC
Am J Clin Nutr; 2008 Sep; 88(3):706-13. PubMed ID: 18779287
[TBL] [Abstract][Full Text] [Related]
20. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
